Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NAPRT | Q6XQN6 | 4/20 | 0.60 |
| ▸ | TSHR | P16473 | 1/20 | 0.60 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.60 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.40 |
| ▸ | MEN1 | O00255 | 1/20 | 0.40 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.39 |
| ▸ | APP | P05067 | 1/20 | 0.39 |
| ▸ | GAA | P10253 | 1/20 | 0.39 |
| ▸ | HCAR3 | P49019 | 1/20 | 0.39 |
| ▸ | HCAR2 | Q8TDS4 | 1/20 | 0.39 |
| ▸ | PLOD2 | O00469 | 2/20 | 0.36 |
| ▸ | TAAR1 | Q96RJ0 | 1/20 | 0.36 |
| ▸ | PLOD3 | O60568 | 1/20 | 0.36 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.36 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.36 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.36 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.36 |
| ▸ | HPGD | P15428 | 1/20 | 0.36 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.36 |
| ▸ | PLOD1 | Q02809 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Pyridine SCHEMBL9851406 | 1.00 | NAPRT (0.60) | NAPRTTSHRTDP1KMT2AMEN1 | |
| Pyridine SCHEMBL6730524 | 0.93 | NAPRT (0.60) | NAPRTTSHRTDP1KMT2AMEN1 | |
| Pyridine SCHEMBL360206 | 0.90 | NAPRT (0.56) | NAPRTTSHRTDP1KMT2AMEN1 | |
| Pyridine SCHEMBL29133271 | 0.90 | NAPRT (0.56) | NAPRTTSHRTDP1KMT2AMEN1 | |
| Pyridine SCHEMBL4636073 | 0.89 | — | — | |
| Pyridine SCHEMBL8916332 | 0.88 | NAPRT (0.53) | NAPRTTSHRTDP1KMT2AMEN1 | |
| Pyridine SCHEMBL27310910 | 0.88 | NAPRT (0.53) | NAPRTTSHRTDP1KMT2AMEN1 | |
| Pyridine SCHEMBL367908 | 0.88 | NAPRT (0.53) | NAPRTTSHRTDP1KMT2AMEN1 | |
| Pyridine SCHEMBL27894846 | 0.87 | NAPRT (0.60) | NAPRTTSHRTDP1KMT2AMEN1 | |
| Pyridine SCHEMBL5278800 | 0.86 | NAPRT (0.69) | NAPRTTSHRTDP1KMT2AMEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 101 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2978750-B1 | \"SYNTHESIS OF DABIGATRAN\ | USV PRIVATE LTD (IN) | 2020-03-04 | — | — | EP | claimed |
| US-9688657-B2 | Synthesis of dabigatran | USV PRIVATE LIMITED (IN) | 2017-06-27 | — | — | US | claimed |
| US-20160060248-A1 | SYNTHESIS OF DABIGATRAN | USV PRIVATE LIMITED (IN) | 2016-03-03 | — | — | US | claimed |
| EP-2978750-A2 | \"SYNTHESIS OF DABIGATRAN\ | USV Limited (IN) | 2016-02-03 | — | — | EP | claimed |
| WO-2014167577-A2 | \"SYNTHESIS OF DABIGATRAN\ | USV LIMITED (IN) | 2014-10-16 | — | — | WO | claimed |
| US-8212034-B2 | Process for preparing rosuvastatin calcium | AUROBINDO PHARMA LTD. (IN) | 2012-07-03 | — | — | US | claimed |
| US-20100029940-A1 | PROCESS FOR PREPARING ROSUVASTATIN CALCIUM | AUROBINDO PHARMA LTD (IN) | 2010-02-04 | — | — | US | claimed |
| CN-100443471-C | Chemical synthesis method of 4-amino-3,5,6-trichloropyridine-2-formic acid | SICHUAN MIANYANG LIER CHEMICAL (CN) | 2008-12-17 | — | — | CN | claimed |
| WO-2008072078-A1 | AN IMPROVED PROCESS FOR PREPARING ROSUVASTATIN CACLIUM | AUROBINDO PHARMA LIMITED (IN) | 2008-06-19 | — | — | WO | claimed |
| CN-1923810-A | Chemical synthesis method of 4-amino-3,5,6-trichloropyridine-2-formic acid | SICHUAN MIANYANG LIER CHEMICAL (CN) | 2007-03-07 | — | — | CN | claimed |
| EP-1015663-A1 | CORROSION INHIBITION THROUGH THE USE OF A QUATERNARY PYRIDINE SALT-HYDROCARBON COMBINATION | Stanchem Inc. (CA) | 2000-07-05 | — | — | EP | claimed |
| WO-1998033953-A1 | CORROSION INHIBITION THROUGH THE USE OF A QUATERNARY PYRIDINE SALT-HYDROCARBON COMBINATION | STANCHEM INC. (CA) | 1998-08-06 | — | — | WO | claimed |
| EP-0024382-B1 | PIPERIDINE DERIVATIVES, THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM | af Ekenstam, Bo (SE) | 1984-03-07 | — | — | EP | claimed |
| EP-0024382-A1 | Piperidine derivatives, their preparation and pharmaceutical compositions containing them | af Ekenstam, Bo (SE) | 1981-03-04 | — | — | EP | claimed |
| JP-1029397-A | — | — | None | — | — | JP | disclosed |
| JP-58203995-A | — | — | None | — | — | JP | disclosed |
| CN-107108493-B | Oxazoline compounds substituted by carbocyclic fused ring systems | 巴斯夫欧洲公司 | 2021-03-23 | — | — | CN | disclosed |
| US-4072810-A | FREE RADICAL CROSSLINKING OF UNSATURATED POLYMERS AND POLYMERIZATION CATALYSTS | PENNWALT CORPORATION (US) | 1978-02-07 | — | — | US | disclosed |
| US-3965145-A | FREE RADICALS | PENNWALT CORPORATION (US) | 1976-06-22 | — | — | US | disclosed |
| US-3963673-A | Polymer crosslinking with coupled peroxides | PENNWALT CORPORATION (US) | 1976-06-15 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160060248-A1 | SYNTHESIS OF DABIGATRAN | ESD, F2, PROC | NAPRT 739/4885TSHR 2743/4885TDP1 1714/4885 |
| US-20100029940-A1 | PROCESS FOR PREPARING ROSUVASTATIN CALCIUM | CACNA1E, SLC5A6, QDPR | NAPRT 1980/4885TSHR 4457/4885TDP1 4428/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.